Adcytherix SASFinancingADC specialist Adcytherix SAS raises €105m in Series A roundFrench ADC start-up Adcytherix SAS has added €105m Series A funding to a €30m seed financing round closed last year. With the money, the company will start a Phase I study with its lead ADCX-020 … more ➔
Tubulis GmbHADCTubulis secures €308m in record-breaking Series C financing Munich-Martinsried-based biotech Tubulis has closed a €308 million (USD 361 million) Series C financing round – the largest of its kind for a still existing European biotechnology company at the … more ➔
BioMed NVMainz BioMed NVBlood test detects pancreatic cancer earlyMainz Biomed NV may have taken a major step in early pancreatic cancer detection. The company reports that its multivariate RNA liquid biopsy test, licensed from Liquid Biosciences Inc. in March, achieved … more ➔
AstraZeneca IncUS marketAstraZeneca agrees to MFN price reductions with US governmentUK-based AstraZeneca plc has become the second of 17 pharmaceutical companies, after Pfizer Inc., to accept U.S. President Donald Trump’s proposal to voluntarily lower drug prices and move production … more ➔
Asebio - Miguel MéndezInterviewBioSpain 2025: “Building European biotech resilience”At BioSpain 2025 European Biotechnology spoke with AseBio CEO Ion Arocena about Spain’s expansion in biotech and its role in a time of geopolitical tensions. more ➔
Novo NordiskNovo NordiskNovo buys again: 5-billion-dollar deal for Akero´s MASHNovo Nordisk is to acquire US-based Akero Therapeutics in a US$5.2 billion deal aimed at reviving growth and entering the MASH-space where others like Roche and GSK have recently expanded their foot … more ➔
AseBioEventBioSpain 2025 starts with new recordsBioSpain 2025 opened in Barcelona, the capital of Catalonia, setting a new record for both visitors and exhibitors. During the inauguration, representatives from government and industry highlighted the … more ➔
Pixabay.comHeart failureEuphoria in Milan: Italian Nanophoria closes €83m financing round in heart failureItalian NanoPhoria Bioscience raises surprisingly high €83.5 million to advance novel heart failure therapy with a very early non clinical asset. more ➔
Owlstone Medical Ltd.CancerBritish Owlstone Medical wins ARPA-H award, but will it materialize?Owlstone Medical, a pioneer in breath-based diagnostics from Cambridge (UK), has been awarded up to US$49.1m by the U.S. health innovation agency ARPA-H under its POSEIDON programme. The funding backs … more ➔
Roche Diagnostics InternationalAIRoche gets CE mark for chronic kidney disease algorithmRoche Diagnostics and its partner KlinRisk Inc have received the EU CE mark for the very first AI-based risk stratification tool that reliably assesses progressive decline in kidney function. more ➔